| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 03/01/2012 | US20120053167 Triazine Derivatives as Kinase Inhibitors |
| 03/01/2012 | US20120053161 Topical solution formulations containing a corticosteroid and a cyclodextrin |
| 03/01/2012 | US20120053159 Isotopologues of lenalidomide |
| 03/01/2012 | US20120053144 Cobalamin Taxane Bioconjugates For Treating Eye Disease |
| 03/01/2012 | US20120053140 Administration of avermectin/milbemycin compounds for the treatment of ophthalmic pathologies |
| 03/01/2012 | US20120052292 Novel medical device coatings |
| 03/01/2012 | US20120052096 Novel dioxo-imidazolidine derivatives, which inhibit the enzyme soat-1, and pharmaceutical and cosmetic compositions containing them |
| 03/01/2012 | US20120052094 Agonists of Neurotrophin Receptors and Their Use as Medicaments |
| 03/01/2012 | US20120052074 Human monoclonal antibodies to activin receptor-like kinase-1 |
| 02/29/2012 | EP1480677B1 Composition for stabilizing hyaluronic acid |
| 02/29/2012 | CN102365093A Prophylactic or therapeutic agent for retinal diseases and method for preventing or treating retinal diseases, each comprising jnk (c-jun n-terminal kinase)-inhibiting peptide, and use of the peptide |
| 02/29/2012 | CN102365086A Composition for alleviating ultraviolet radiation-induced damage |
| 02/29/2012 | CN102363629A Protein for treating eye angiogenesis |
| 02/29/2012 | CN102362931A Medicinal liquor for treating deafness |
| 02/29/2012 | CN102362924A Medicinal composition for treating ophthalmic diseases and preparation method thereof |
| 02/29/2012 | CN102106907B Quality control method for rhubarb (traditional Chinese medicine) ethanol-extraction process |
| 02/29/2012 | CN102058749B Chinese medicinal composition for treating cataract |
| 02/29/2012 | CN102038785B Detection method for traditional Chinese medicinal preparation of children eyesight pills |
| 02/29/2012 | CN101857860B Application of viral nucleic acid sequence strictly conservative area as siRNA design template |
| 02/29/2012 | CN101704785B Organic dicarboxylic acid and salts thereof and preparation method thereof |
| 02/29/2012 | CN101693075B Traditional Chinese medicine for treating senile cataract |
| 02/29/2012 | CN101549159B Application of the hydroxypropyl-belta-cyclodextrin in eyedrops of chloramphenicol and method thereof |
| 02/29/2012 | CN101400659B Novel 1,2,3,4-tetrahydroquinoxaline derivative having glucocorticoid receptor binding activity |
| 02/29/2012 | CN101313899B Medicament composition for eyes containing sodium bromfenac |
| 02/28/2012 | US8124638 Tricyclic compounds useful as angiotensin II agonists |
| 02/28/2012 | US8124590 Biodegradable immunomodulatory formulations and methods for use thereof |
| 02/23/2012 | WO2012024376A1 Ep2 or ep4 agonists for treating corneal haze |
| 02/23/2012 | WO2012003554A3 Compositions and methods for removal or destruction of amyloid fibril or amyloid adhesin comprising aggregates |
| 02/23/2012 | WO2011131765A3 Artificial tear emulsion |
| 02/23/2012 | WO2011130356A9 Systems and methods for activating cross-linking in an eye |
| 02/23/2012 | US20120046344 Treatment of lipid transport and metabolism gene related diseases by inhibition of natural antisense transcript to a lipid transport and metabolism gene |
| 02/23/2012 | US20120046332 Compositions and methods for treating corneal haze |
| 02/23/2012 | US20120046330 Pharmaceutical compositions of (r)-1-(2,2-difluorobenzo[d] [1,3]dioxol-5-yl)-n-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1h-indol-5-yl) cyclopropanecarboxamide and administration thereof |
| 02/23/2012 | US20120046320 Beta- and gamma-diketones and gamma-hydroxyketones as wnt/beta-catenin signaling pathway activators |
| 02/23/2012 | US20120046317 Novel heterocyclic compounds |
| 02/23/2012 | US20120046303 Benzimidazole poly(adp ribose)polymerase inhibitors |
| 02/23/2012 | US20120046301 Substituted Cyclic Carboxamide and Urea Derivatives as Ligands of the Vanilloid Receptor |
| 02/23/2012 | US20120046293 Renin inhibitors |
| 02/23/2012 | US20120046285 Bradykinin receptor agonists and uses thereof to treat ocular hypertension and glaucoma |
| 02/23/2012 | US20120046275 Cytoskeletal active rho kinase inhibitor compounds, composition and use |
| 02/23/2012 | US20120046274 6-alkenyl and 6-phenylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(adp-ribose) polymerase inhibitors |
| 02/23/2012 | US20120046269 Novel Amino Azaheterocyclic Carboxamides |
| 02/23/2012 | US20120046218 Glycosaminoglycan-antagonising mcp-i mutants and methods of using same |
| 02/23/2012 | US20120046217 TNF-alpha Antagonists Containing IGFBP5 |
| 02/23/2012 | US20120045503 Compositions And Methods For Wound Healing |
| 02/23/2012 | US20120045500 Novel dioxo-imidazolidine derivatives, which inhibit the enzyme soat-1, and pharmaceutical and cosmetic compositions containing them |
| 02/23/2012 | US20120045454 2,4-pyrimidinediamine compounds and their uses |
| 02/23/2012 | US20120045437 MONOCLONAL ANTIBODIES THAT INHIBIT THE Wnt SIGNALING PATHWAY AND METHODS OF PRODUCTION AND USE THEREOF |
| 02/23/2012 | US20120045435 Compositions and methods to inhibit stem cell and progenitor cell binding to lymphoid tissue and for regenerating germinal centers in lymphatic tissues |
| 02/23/2012 | US20120045420 Compositions and improved soft tissue replacement methods |
| 02/23/2012 | US20120045394 Human and mouse targeting peptides identified by phage display |
| 02/23/2012 | DE102010034699A1 Pyrimidinderivate Pyrimidine derivatives |
| 02/23/2012 | CA2808407A1 Ep2 or ep4 agonists for treating corneal haze |
| 02/23/2012 | CA2807419A1 Diketones and hydroxyketones as catenin signaling pathway activators |
| 02/22/2012 | EP2420572A1 Monoclonal antibody capable of binding to specific discontinuous epitope occurring in ad1 region of human cytomegalovirus gb glycoprotein, and antigen-binding fragment thereof |
| 02/22/2012 | EP2420501A1 Novel compound having 3-heteroarylpyrimidin-4-(3h)-one structure and pharmaceutical preparation containing same |
| 02/22/2012 | EP2420239A2 Antiangiogenic agents |
| 02/22/2012 | EP2420238A2 Anti-angiogenic agents |
| 02/22/2012 | EP2420236A2 Anti-angiogenic agents |
| 02/22/2012 | EP2420230A2 Antiangiogenic agents |
| 02/22/2012 | EP2419425A1 Imidazole substituted pyrimidines useful in the treatment of glycogen synthase kinase 3 related disorders such as alzheimer's disease |
| 02/22/2012 | EP2419412A1 Compositions and methods for modulating retinol binding to retinol binding protein 4 (rbp4) |
| 02/22/2012 | EP2419399A1 Compositions and methods for the treatment of inflammation |
| 02/22/2012 | EP2419118A1 Treating blurred vision and other conditions of the eye with cyclosporin composition |
| 02/22/2012 | EP2419107A1 Method and composition for treating macular degeneration |
| 02/22/2012 | EP2419105A1 Use of transforming growth factor-b receptor inhibitors to suppress ocular scarring |
| 02/22/2012 | EP2419097A1 Pharmaceutical compositions |
| 02/22/2012 | EP1648494B1 Anti-angiogenetic agent and its use in cancer treatment |
| 02/22/2012 | EP1541151B1 REMEDY FOR GLAUCOMA COMPRISING Rho KINASE INHIBITOR AND PROSTAGLANDINS |
| 02/22/2012 | CN102357243A Recombinant cattle basic fibroblastic growth factor eye drops |
| 02/22/2012 | CN102357196A External traditional Chinese medicine composition for treating xerophthalmia and preparation method thereof |
| 02/22/2012 | CN102058567B Application of 3',4-dyhydroxyl-3,5'-dimethoxybibenzyl in preparing medicaments for treating cataract |
| 02/22/2012 | CN101856333B 头孢孟多酯钠冻干粉针制剂及其制备方法 Cefamandole ester sodium freeze-dried powder and its preparation method |
| 02/22/2012 | CN101612217B 一种中药组合物在制备治疗中心性浆液性脉络膜视网膜病变的药物中的应用 A composition for use in the preparation of traditional Chinese medicine treatment of Central serous retinopathy medicament |
| 02/22/2012 | CN101306121B 一种治疗急性结膜炎的熏洗药物 A method of treating acute conjunctivitis drug fumigation |
| 02/22/2012 | CN101301358B 一种治疗溃疡性睑缘炎的外洗药物 Outside a drug to treat ulcerative blepharitis wash |
| 02/22/2012 | CN101163474B 角膜结膜病变治疗剂 Corneal and conjunctival lesion therapeutic agent |
| 02/21/2012 | US8119687 Derivatives of dioxan-2-alkyl carbamates, preparation thereof and application thereof in therapeutics |
| 02/21/2012 | US8119609 Apoptosis and increased production of ceramides and DAG are normalized in the presence of antioxidants |
| 02/21/2012 | US8119370 Activatable recombinant neurotoxins |
| 02/21/2012 | US8119121 Delivering a concentrated amount of stem cells obtained from adipose tissue to a patient |
| 02/21/2012 | CA2659184C Ep2 agonists |
| 02/21/2012 | CA2488372C Pyridazine derivatives which are phosphodiasterase iv inhibitors |
| 02/21/2012 | CA2472399C Pharmaceutical compositions comprising valsartan and nep inhibitors |
| 02/21/2012 | CA2451981C 2,4,5-trisubstituted thiazolyl derivatives and their antiinflammatory activity |
| 02/21/2012 | CA2444031C 3,4-di-substituted cyclobutene-1,2-diones as cxc-chemokine receptor ligands |
| 02/21/2012 | CA2400141C Pharmaceutical compositions containing azetidine derivatives, novel azetidine derivatives and preparation thereof |
| 02/21/2012 | CA2328074C Methods and compositions using terfenadine metabolites in combination with leukotriene inhibitors |
| 02/16/2012 | WO2012021466A2 Use of extracts of pezizaceae in the prevention and/or treatment of senile cataracts |
| 02/16/2012 | WO2012020767A1 Pyrroloquinoline quinone gel |
| 02/16/2012 | WO2012020040A1 Injectable pharmaceutical composition for preventing, stabilising and/or inhibiting pathological neovascularization-related conditions |
| 02/16/2012 | WO2012020001A1 Methods and pharmaceutical compositions for the treatment of an ocular disease in a subject |
| 02/16/2012 | WO2012019439A1 Huperzine a ophthalmic microemulsion and preparation method thereof |
| 02/16/2012 | WO2012019428A1 Benzohydrol derivatives, a preparation process and pharmaceutical use thereof |
| 02/16/2012 | WO2011132084A3 Therapeutic regimen and method for treating or ameliorating visual disorders associated with an endogenous retinoid deficiency |
| 02/16/2012 | US20120041073 Stabilized mutant opsin proteins |
| 02/16/2012 | US20120041047 Injectable Pharmaceutical Composition for Preventing, Stabilizing and/or Inhibiting Pathological Neovascularization-Related Conditions |
| 02/16/2012 | US20120041039 Amine derivative compounds for treating ophthalmic diseases and disorders |
| 02/16/2012 | US20120041038 Amine derivative compounds for treating ophthalmic diseases and disorders |
| 02/16/2012 | US20120041031 Method of activating regulatory t cells with alpha-2b adrenergic receptor agonists |